carbapenems has been researched along with Opportunistic Infections in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R | 1 |
| Glaser, A; Jahangir, A; Mobarakai, N; Sahra, S; Sharif, MA | 1 |
| Bashar, S; Hossain, MA; Sanyal, SK; Sultana, M | 1 |
| Hagiwara, K; Hirama, T; Kanazawa, M; Kawana, H; Kawashima, A; Masumoto, A; Mio, T; Nagata, M; Shiono, A | 1 |
| Chung, PY | 1 |
| Catherinot, E; Degand, N; Lanternier, F; Lebeaux, D; Lecuit, M; Lortholary, O; Mainardi, JL; Podglajen, I; Rubio, MT; Suarez, F | 1 |
| Juan Nicolau, C; Oliver, A | 1 |
| Cohen, R; Durrmeyer, X | 1 |
| Watanabe, K | 1 |
| Bogiel, T; Gospodarek, E; Jachna-Sawicka, K; Kwiecińska-Piróg, J | 1 |
| Akcay, MN; Aktas, F; Altoparlak, U; Celebi, D; Ozkurt, Z | 1 |
| Bycroft, B; Cox, ARJ; Salmond, GPC; Stewart, GSAB; Thomson, NR; Williams, P | 1 |
4 review(s) available for carbapenems and Opportunistic Infections
| Article | Year |
|---|---|
The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biofilms; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Opportunistic Infections; Urinary Catheters | 2016 |
[Carbapenemases in Pseudomonas spp].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genes, Bacterial; Humans; Opportunistic Infections; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors | 2010 |
[Pediatric use of carbapenems].
Topics: Bacterial Infections; Carbapenems; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Utilization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Opportunistic Infections; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
8 other study(ies) available for carbapenems and Opportunistic Infections
| Article | Year |
|---|---|
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome | 2021 |
First case report of acute cholangitis secondary to Cronobacter sakazakii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cholangitis; Cholecystostomy; Cronobacter sakazakii; Drainage; Enterobacteriaceae Infections; Humans; Male; Opportunistic Infections; Polymerase Chain Reaction; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Emergence of IntI1 associated bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Integrases; Integrons; Microbial Sensitivity Tests; Opportunistic Infections; Protein Binding; Pseudomonas Infections; Pseudomonas stutzeri | 2017 |
[Case report; a case of lung and skin nocardiosis in a non-immunocompromised patient].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Diagnosis, Differential; Doripenem; Drainage; Humans; Male; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Radiography, Thoracic; Skin Diseases, Bacterial; Sputum; Suppuration; Tomography, X-Ray Computed | 2013 |
Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation.
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Drug Resistance, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Nocardia; Nocardia Infections; Opportunistic Infections; Pneumonia, Bacterial; Radiography, Thoracic; Tomography | 2010 |
[Carbapenem-resistant Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Adult; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Cross Infection; Drug Resistance, Microbial; Hospitals, University; Humans; Opportunistic Infections; Pharynx; Poland; Species Specificity; Wounds and Injuries | 2010 |
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Burns; Carbapenems; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
A pheromone-independent CarR protein controls carbapenem antibiotic synthesis in the opportunistic human pathogen Serratia marcescens.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cloning, Molecular; Cosmids; Erwinia; Escherichia coli; Genetic Complementation Test; Humans; Molecular Sequence Data; Opportunistic Infections; Pheromones; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serratia marcescens | 1998 |